Chantal Spurdon
Obstetrics & Gynecology · Bedford, TXNPI 1952442022
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AbbVie at 25.6% of the total. Reporting peaked in 2019 at $1,039 and has fallen 59.7% since, to $418 in 2022.
Across 107 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$539
- Pfizer$237
- Exeltis, USA Inc.$146
- Vertical Pharmaceuticals, LLC$107
- Merck$104
- Organon$98
- plus $872 from 28 others
What the payments were for
- Food & beverage$2,02596%
- Education$774%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 20 | $539 |
| Pfizer | 13 | $237 |
| Exeltis, USA Inc. | 9 | $146 |
| Vertical Pharmaceuticals, LLC | 6 | $107 |
| Merck | 6 | $104 |
| Organon | 5 | $98 |
| AMAG Pharmaceuticals, Inc. | 5 | $77 |
| Avion Pharmaceuticals | 4 | $69 |
| Mission Pharmacal Company | 3 | $52 |
| Duchesnay USA Incorporated | 3 | $50 |
| Mayne Pharma Commercial LLC | 2 | $46 |
| Myovant Sciences Inc. | 2 | $42 |
| Agile Therapeutics, Inc. | 3 | $42 |
| Therapeuticsmd, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $40 |
| Covidien LP | 1 | $39 |
| Aspira Women's Health Inc | 1 | $33 |
| Evofem Biosciences, Inc. | 2 | $32 |
| Scynexis, Inc. | 2 | $31 |
| Lupin Inc. | 2 | $28 |
| Coopersurgical, Inc. | 1 | $24 |
| Abbott | 1 | $24 |
| Roche Diagnostics Corporation | 1 | $23 |
| Bayer | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Shield Therapeutics Inc | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Smith+Nephew | 1 | $15 |
| Ascend Therapeutics US, LLC | 1 | $15 |
| Minerva Surgical, Inc | 1 | $14 |
| LSI Solutions Inc | 1 | $13 |
| Millicent US Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$104
How this compares
$2,102 in reported general payments places this provider in the 65th percentile of 3,099 obstetrics & gynecology providers in Texas.
Other obstetrics & gynecology in Bedford
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.